Journal of Clinical Immunology

, Volume 20, Issue 6, pp 477–485

Primary Immunodeficiency Diseases in Norway

  • Asbjørg Stray-Pedersen
  • Tore G. Abrahamsen
  • Stig S. Frøland


This study represents the first national epidemiological survey of primary immunodeficiency diseases in Norway. Uniform questionnaires were sent out in April 1998 to all hospital departments considered relevant. As of February 1999, a total of 372 patients have been registered, of whom 69 patients are deceased. With a population of 4.45 million people, the total prevalence of primary immunodeficiency diseases in Norway February 1, 1999 is 6.82 per 100.000 inhabitants. Distribution between the main immunodeficiency diagnoses is (a) antibody deficiencies 50.8%, (b) combined deficiencies included other immunodeficiency syndromes 12.4%, (c) complement deficiencies 21.0%, (d) phagocytic disorders 6.7%, (e) and immunodeficiency associated with other congenital diseases 9.1%. Compared to previous reports from other European countries, there is a smaller proportion of antibody deficiencies due to few IgA deficiencies registered and a large proportion of complement deficiencies due to many patients with hereditary angioedema.

Primary immunodeficiency registry Norway 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ochs HD, Smith CIE, Puck JM: Primary Immunodeficiency Diseases, a Molecular and Genetic Approach. Oxford University Press, New York 1999Google Scholar
  2. 2.
    Abedi MR, Morgan G, Goii H, Paganelli R, Matamoros N, Hammarstrøm L: Report from the ESID Registry of Primary Immunodeficiencies. Extended Abstracts. VIII Meeting of the European Society for Immunodeficiencies, Rhodes, Greece, ESID 1998. Mol Immunol 35:645-647, 1998Google Scholar
  3. 3.
    Gooi HC: Primary immunodeficiency register, United Kingdom: Update 1992. Immunodeficiency 4:191-192, 1993Google Scholar
  4. 4.
    Toolan J, Gooi HC: Primary immunodeficiency register, United Kingdom 1998. Abstracts, IX Meeting of the European Society for immunodeficiencies, Rhodes, Greece, ESID 1998. Mol Immunol 35:804, 1998Google Scholar
  5. 5.
    Fasth A: Primary immunodeficiency disorders in Sweden: Cases among children 1974–1979. J Clin Immunol 2:86-92, 1982Google Scholar
  6. 6.
    Ryser O, Morell A, Hitzig WH: Primary immunodeficiencies in Switzerland: First report of the national registry in adults and children. J Clin Immunol 8:479-485, 1988Google Scholar
  7. 7.
    Affentranger P, Morell A, Spath P, Seeger R: Registry of primary immunodeficiencies in Switzerland. Immunodeficiency 4:193-195, 1993Google Scholar
  8. 8.
    Luizi G, Pesce AM, Rinaldi S: Primary immunodeficiencies in Italy. Data revised from the Italian Register of Immunodeficiencies-IRID (1977–1988). Immunol Clin 8(1):45-54, 1989Google Scholar
  9. 9.
    Luizi G, Businco L Auiti F: Primary immunodeficiency syndromes in Italy: A report of the national register in children and adults. J Clin Immunol 3:316-321, 1983Google Scholar
  10. 10.
    Matamoros Flori N, Mila Llambi J, Espanol Boren T, Raga Borja S, Fontan Casariego G: Primary immunodeficiency syndrome in Spain: First report of the National Registry in Children and Adults. J Clin Immunol 17:333-339, 1997Google Scholar
  11. 11.
    Hayakawa H, Jwata T, Kobayashi N: Primary immunodeficiency syndrome in Japan. I. Overview of a national-wide survey on primary immunodeficiency. J Clin Immunol 1:31-39, 1981Google Scholar
  12. 12.
    al-Attas RA, Rahi AH: Primary antibody deficiency in Arabs: First report from eastern Saudi Arabia. J Clin Immunol 18:368-371, 1998Google Scholar
  13. 13.
    Baumgart KW, Britton WJ, Kemp A, French M, Roberton D: The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol 100:415-423, 1997Google Scholar
  14. 14.
    Zelazko M, Carneiro-Sampaio M, Cornejo de Luigi M, Garcia de Olarte D, Porras Madrigal O, Berron Perez R, Cabello A, Rostan MV, Sorensen RU: Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases. J Clin Immunol 18:161-166, 1998Google Scholar
  15. 15.
    Smith CIE, Vihinen M: Immunodeficiency mutation databases-a new research tool. Immunol Today 17:495-496, 1996Google Scholar
  16. 16.
    Vihinen M, Brandau O, Branden LJ, Kwan SP, Lappalainen I, Lester T. Noordzij JG, Ochs HD, Ollila J, Pienaar SM, Riikonen P, Saha BK, Smith CIE: BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res 26:242-247, 1998Google Scholar
  17. 17.
    Holinski-Feder E, Weiss M, Brandau O, Jedele KB, Nore B, Backesjo CM, Vihinen M, Hubbard SR, Belohradsky BH, Smith CI, Meindl A: Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics 101:276-284, 1998Google Scholar
  18. 18.
    Schwarz K, Nonoyama S, Peitsch MC, de Saint Basile G, Espanol T, Fasth A, Fischer A, Freitag K, Friedrich W, Fugmann S, Hossle JP, Jones A, Kinnon C, Meindl A, Notarangelo LD, Wechsler A, Weiss M, Ochs HD: WASPbase: A database of WAS-and XLT-causing mutations. Immunol Today 17:496-502, 1996Google Scholar
  19. 19.
    Schwartz M, Bekassy A, Donner M, Hertel T, Hreidarson S, Kerndrup G, Stormorken H, Stokland T, Tranebjaerg L, Orstavik KH, Skovby F: Mutation spectrum in patients with Wiskott–Aldrich syndrome and X-linked thrombocytopenia: Identification of twelve different mutations in the WASP gene. Thrombosis Haemostasis 75:546-550, 1996Google Scholar
  20. 20.
    Puck JM, Pepper AE, Henthorn PS, Candotti F, Isakov J, Whitwam T, Conley ME, Fischer RE, Rosenblatt HM, Small TN, Buckley RH: Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 89:1968-1977, 1997aGoogle Scholar
  21. 21.
    Notarangelo LD, Peitsch MC, Abrahamsen TG, Bachelot C, Bordigoni P, Cant AJ, Chapel H, Clementi M, Deacock S, de Saint Basile G, Duse M, Espanol T, Etzioni A, Fasth A, Fischer A, Giliani S, Gomez L, Hammarström L, Jones A, Kanariou M, Kinnon C, Klemola T, Kroczek RA, Levy J, Matamoros N, Monfao V, Paolucci P, Reznick I, Sanal O, Smith CIE, Thompson RA, Tovo P, Villa a, Vihinen M, Vossen J, Zegers BJM, Ochs HD, Conley ME, Iseki M, Ramesh N, Shimadzu M, Saiki O: CD40lbase: A database of CD40L gene mutations causing Xlinked hyper-IgM syndrome. Immunol Today 17:511-516, 1996Google Scholar
  22. 22.
    Roos D, Curnutte JT, Hossle JP, Lau YL, T Ariga, Nunoi H, Dinauer MC, Gahr M, Segal AW, Newburger PE, Giacca M, Keep NH, van Zwieten R: X-CGDbase: A database of X-CGD-causing mutations. Immunol Today 17:517-521, 1996Google Scholar
  23. 23.
    Winkelstein JA, Tymes D, Boyle J, Buckley RH, Curnutte JT, Dickler HB, Gallin JI, Johnston RB, Malech HL, Ochs HD, Quie P: Report on the United States Registry of patients with chronic granulomatous disease (CGD), Abstracts, VIII Meeting of the European Society for immunodeficiencies, Göteborg, Sweden, ESID 1996Google Scholar
  24. 24.
    Welte K, Dale D: Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol 72:158-165, 1996Google Scholar
  25. 25.
    Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA: A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125(Pt 1):876-85, 1994Google Scholar
  26. 26.
    Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, Roberts JL, Puck JM: Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 130:378-387, 1997Google Scholar
  27. 27.
    Levy J, Espanol-Boren T, Thomas C, Fisher A, Tovo P, Bordigino P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monofono V, Abinun M, Hammarström L, Abrahamsen TG, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD: Clinical spectrum of X-linked hyper IgM syndrome. J Pediatr 131:47-54, 1997Google Scholar
  28. 28.
    The Norwegian Ministry of Health and Social Affairs: Folkehelserapporten 1999 [Report of Public Health and Welfare] [Norwegian], 1999Google Scholar
  29. 29.
    The Norwegian Ministry of Health and Social Affairs: [Access to health registries] [Norwegian] NOU 26, 1997Google Scholar
  30. 30.
    Primary immunodeficiency diseases. Report of a WHO scientific group. Clin Exp Immunol 109(Suppl 1):1-28, 1997Google Scholar
  31. 31.
    Statistics Norway: Statistisk årbok 1998 [Statistical report], 1998Google Scholar
  32. 32.
    Laake K, Telatar M, Geitvik GA, Hansen RO, Heiberg A, Andresen AM, Gatti R, Borresen-Dale AL: Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families: evidence for a founder effect. Eur J Hum Genet 6:235-244, 1998Google Scholar
  33. 33.
    Nielsen EW, Gran JT, Straume B, Mellbye OJ, Johansen HT, Mollnes TE: Hereditary angio-oedema: New clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J Internal Med 239:119-130, 1996Google Scholar
  34. 34.
    Rogde S, Høiby EA, Teisberg P, Olaisen B: Genetic aspects of complement component C8 in Norwegian meningococcal disease patients. Scand J Infect Dis 22:673-679, 1990Google Scholar
  35. 35.
    Hogasen K, Michaelsen T, Mellbye OJ, Bjune G: Low prevalence of complement deficiencies among patients with meningococcal disease in Norway. Scand J Immunol 37:487-489, 1993Google Scholar
  36. 36.
    Sullivan KE, Petri MA, Schmeckpeper BJ, McLean RH, Winkelstein JA: Prevalence of a mutation causing C2 deficiency in systemic lupus erytrematousus. J Reumatol 21:1128-1133, 1994Google Scholar
  37. 37.
    Vesterhus P, Holland SM, Abrahamsen TG, Bjerknes R: Familial disseminated infection due to atypical mycobacteria with childhood onset. Clin Infect Dis 27:822-825, 1998Google Scholar
  38. 38.
    Lie SO, Frøland SS, Brandtzaeg P, Steen-Johnsen J, Vandvik B: Transient B cell immaturity with intractable diarrhoea: A possible new immunodeficiency syndrome. J Inherit Metabolic Dis 1:137-143, 1978Google Scholar
  39. 39.
    Grimbacher B, Holland SM, Gallin JI, Greenberg F, Suvimol CH, Malech HL, Miller JA, O'Connell AC, Puck JM: Hyper-IgE syndrome with recurrent infections-An autosomal dominant multisystem disorder. N Engl J Med 340:692-702, 1999Google Scholar
  40. 40.
    Ahonen P, Myllarniemi S, Sipila I, Perheentupa J: Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829-1836, 1990Google Scholar
  41. 41.
    Finnish-German APECED Consortium: An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Genet 17:399-403, 1997Google Scholar
  42. 42.
    Wilson JG, Yount WJ, Dillard SB: Chronic mucocutaneous candidiasis: Immunologic studies of three generations of a single family. Am J Med 67:948-959, 1979Google Scholar
  43. 43.
    Zhu Q, Watanabe C, Liu T, Hollenbach D, Blaese RM, Kanner SB, Aruffo A, Ochs HD: Wiscott-Aldrich syndome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood 90:2680-2689, 1997Google Scholar
  44. 44.
    Ahlin A, De Boer M, Roos D, Leusen J, Smith CI, Sundin U, Rabbani H, Palmblad J, Elinder G: Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatrica 84(Suppl 12):1386-1394, 1995.Google Scholar

Copyright information

© Plenum Publishing Corporation 2000

Authors and Affiliations

  • Asbjørg Stray-Pedersen
    • 1
  • Tore G. Abrahamsen
    • 2
  • Stig S. Frøland
    • 3
  1. 1.The Centre for Rare Disorders, Department of Medicine, RikshospitaletUniversity of OsloOsloNorway
  2. 2.Department of Pediatrics, Department of Medicine, RikshospitaletUniversity of OsloOsloNorway
  3. 3.Section of Clinical Immunology and Infectious Diseases, Department of Medicine, RikshospitaletUniversity of OsloOsloNorway

Personalised recommendations